Paraneoplastic neurological syndromes and the role of PET imaging

dc.contributor.authorSioka, C.en
dc.contributor.authorFotopoulos, A.en
dc.contributor.authorKyritsis, A. P.en
dc.date.accessioned2015-11-24T19:00:03Z
dc.date.available2015-11-24T19:00:03Z
dc.identifier.issn1423-0232-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/19469
dc.rightsDefault Licence-
dc.subjectBreast Neoplasms/pathology/radionuclide imagingen
dc.subjectDementia/etiologyen
dc.subjectDiagnosis, Differentialen
dc.subjectFemaleen
dc.subjectFluorodeoxyglucose F18/diagnostic useen
dc.subjectHumansen
dc.subjectImmunotherapy/methodsen
dc.subjectLambert-Eaton Myasthenic Syndrome/radionuclide imagingen
dc.subjectMagnetic Resonance Imagingen
dc.subjectOvarian Neoplasms/pathology/radionuclide imagingen
dc.subjectParaneoplastic Syndromes/diagnosis/pathology/*radionuclide imagingen
dc.subjectParaneoplastic Syndromes, Nervous System/diagnosis/immunology/*radionuclideen
dc.subjectimagingen
dc.subject*Positron-Emission Tomographyen
dc.subjectRadiopharmaceuticals/diagnostic useen
dc.subjectSeizures/etiologyen
dc.subjectTomography, X-Ray Computeden
dc.titleParaneoplastic neurological syndromes and the role of PET imagingen
heal.abstractParaneoplastic neurological syndromes are immune-mediated effects of cancer that involve the nervous system and are associated with various anti-neuronal antibodies. They can be associated with several cancers such as lung, gynecologic, thymic, testicular and others, but the diagnosis of cancer often becomes a challenge, since paraneoplastic neurological syndromes usually precede the cancer presentation by months or even years. Furthermore, even when the cancer develops, the tumor size remains small and usually undetectable by conventional diagnostic tests and imaging. Positron emission tomography imaging may be an adjunct to timely diagnosis of the occult malignancy in order to employ the specific cancer treatment. Furthermore, positron emission tomography can assess the extent of the functional abnormality in the brain and monitor its response to treatment.en
heal.accesscampus-
heal.fullTextAvailabilityTRUE-
heal.identifier.primary10.1159/000312657-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/20389137-
heal.identifier.secondaryhttp://content.karger.com/ProdukteDB/produkte.asp?Aktion=ShowPDF&ArtikelNr=000312657&Ausgabe=254031&ProduktNr=223857&filename=000312657.pdf-
heal.journalNameOncologyen
heal.journalTypepeer-reviewed-
heal.languageen-
heal.publicationDate2010-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.typejournalArticle-
heal.type.elΆρθρο Περιοδικούel
heal.type.enJournal articleen

Αρχεία

Φάκελος/Πακέτο αδειών

Προβολή: 1 - 1 of 1
Φόρτωση...
Μικρογραφία εικόνας
Ονομα:
license.txt
Μέγεθος:
1.74 KB
Μορφότυπο:
Item-specific license agreed upon to submission
Περιγραφή: